Accessibility Menu
Incyte logo

Incyte

(NASDAQ) INCY

Current Price$108.49
Market Cap$20.86B
Since IPO (1993)+5,468%
5 Year+21%
1 Year+55%
1 Month+7%

Incyte Financials at a Glance

Market Cap

$20.86B

Revenue (TTM)

$5.36B

Net Income (TTM)

$1.43B

EPS (TTM)

$7.07

P/E Ratio

14.76

Dividend

$0.00

Beta (Volatility)

0.54 (Low)

Price

$108.49

Volume

58,788

Open

$105.48

Previous Close

$108.49

Daily Range

$105.48 - $109.07

52-Week Range

$66.83 - $112.29

Estimated Earnings Date

Aug 4, 2026

INCY: Motley Fool Moneyball Superscore

79

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Incyte

Industry

Biotechnology

Employees

2,844

CEO

William J. Meury

Headquarters

Wilmington, DE 19803, US

INCY Financials

Key Financial Metrics (TTM)

Gross Margin

92.48%

Operating Margin

27.05%

Net Income Margin

26.71%

Return on Equity

29.31%

Return on Capital

25.64%

Return on Assets

19.51%

Earnings Yield

6.78%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$20.86B

Shares Outstanding

199.78M

Volume

58.79K

Avg. Volume

1.60M

Financials (TTM)

Gross Profit

$4.96B

Operating Income

$1.45B

EBITDA

$1.87B

Operating Cash Flow

$1.52B

Capital Expenditure

-$65.90M

Free Cash Flow

$1.45B

Cash & ST Invst.

$4.02B

Total Debt

$33.83M

Incyte Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$1.27B

+20.9%

Gross Profit

$1.17B

+19.2%

Gross Margin

91.79%

N/A

Market Cap

$20.86B

N/A

Market Cap/Employee

$7.97M

N/A

Employees

2,617

N/A

Net Income

$303.33M

+91.7%

EBITDA

$367.97M

+43.1%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Total Cash

$4.02B

+66.7%

Total Debt

$33.83M

-21.5%

Accounts Receivable

$1.05B

+27.7%

Inventory

$115.62M

+80.7%

Long Term Debt

$29.41M

-9.9%

Short Term Debt

$4.41M

-57.9%

Return on Assets

19.51%

N/A

Return on Invested Capital

24.79%

N/A

Free Cash Flow

$359.15M

+36.6%

Operating Cash Flow

$369.35M

+38.8%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
DGXQuest Diagnostics Incorporated
$203.11+3.01%
UTHRUnited Therapeutics Corporation
$549.90+1.02%
RPRXRoyalty Pharma plc
$54.28-1.93%
WSTWest Pharmaceutical Services, Inc.
$340.41+1.20%

Trending Stocks

Symbol / CompanyPricePrice Chg
WENWendy's
$7.86+0.26%
AALAmerican Airlines Group
$17.44+0.08%
INTCIntel
$131.65-0.00%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$5.27+0.01%

Questions About INCY

What is the current price of Incyte?

Incyte is trading at $108.49 per share.

What is the 52-week range for Incyte?

Over the past 52 weeks, Incyte has traded between $66.83 and $112.29.

How much debt does Incyte have?

As of the most recent reporting period, Incyte reported total debt of $39.43M.

How much cash does Incyte have on hand?

Incyte reported $3.46B in cash and cash equivalents in its most recent financial results.

What is Incyte’s dividend yield?

Incyte does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.